A detailed history of Oak Ridge Investments LLC transactions in Argenx Se stock. As of the latest transaction made, Oak Ridge Investments LLC holds 4,601 shares of ARGX stock, worth $2.5 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
4,601
Previous 5,036 8.64%
Holding current value
$2.5 Million
Previous $1.98 Million 0.2%
% of portfolio
0.19%
Previous 0.2%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$356.01 - $451.55 $154,864 - $196,424
-435 Reduced 8.64%
4,601 $1.98 Million
Q1 2024

May 01, 2024

SELL
$356.95 - $413.29 $106,728 - $123,573
-299 Reduced 5.6%
5,036 $1.98 Million
Q4 2023

Jan 16, 2024

SELL
$338.91 - $506.01 $121,668 - $181,657
-359 Reduced 6.3%
5,335 $2.03 Million
Q3 2023

Oct 30, 2023

SELL
$369.35 - $548.43 $1.34 Million - $1.99 Million
-3,628 Reduced 38.92%
5,694 $2.8 Million
Q2 2023

Aug 07, 2023

BUY
$360.14 - $422.58 $677,783 - $795,295
1,882 Added 25.3%
9,322 $3.63 Million
Q1 2023

Apr 14, 2023

SELL
$334.23 - $403.65 $160,430 - $193,752
-480 Reduced 6.06%
7,440 $2.77 Million
Q4 2022

Jan 24, 2023

SELL
$342.17 - $402.31 $62,959 - $74,025
-184 Reduced 2.27%
7,920 $0
Q3 2022

Nov 08, 2022

SELL
$343.2 - $395.75 $3,775 - $4,353
-11 Reduced 0.14%
8,104 $2.86 Million
Q2 2022

Jul 28, 2022

SELL
$269.58 - $378.88 $127,511 - $179,210
-473 Reduced 5.51%
8,115 $3.08 Million
Q1 2022

Apr 22, 2022

SELL
$254.45 - $351.06 $1.24 Million - $1.71 Million
-4,885 Reduced 36.26%
8,588 $2.71 Million
Q4 2021

Feb 01, 2022

SELL
$272.01 - $353.03 $63,650 - $82,609
-234 Reduced 1.71%
13,473 $4.72 Million
Q3 2021

Nov 05, 2021

SELL
$295.0 - $350.58 $92,040 - $109,380
-312 Reduced 2.23%
13,707 $4.14 Million
Q2 2021

Jul 30, 2021

SELL
$257.11 - $319.92 $278,964 - $347,113
-1,085 Reduced 7.18%
14,019 $4.22 Million
Q1 2021

May 12, 2021

SELL
$268.3 - $380.31 $28.9 Million - $41 Million
-107,860 Reduced 87.72%
15,104 $4.16 Million
Q1 2021

May 04, 2021

BUY
$268.3 - $380.31 $28.9 Million - $40.9 Million
107,566 Added 698.57%
122,964 $33.9 Million
Q4 2020

Feb 03, 2021

SELL
$248.13 - $308.36 $1.03 Million - $1.28 Million
-4,144 Reduced 21.21%
15,398 $4.53 Million
Q3 2020

Nov 12, 2020

SELL
$215.51 - $272.51 $289,214 - $365,708
-1,342 Reduced 6.43%
19,542 $5.13 Million
Q2 2020

Aug 05, 2020

SELL
$127.44 - $232.72 $1.47 Million - $2.68 Million
-11,529 Reduced 35.57%
20,884 $4.7 Million
Q1 2020

May 13, 2020

SELL
$108.83 - $165.23 $566,786 - $860,517
-5,208 Reduced 13.84%
32,413 $4.27 Million
Q4 2019

Feb 05, 2020

SELL
$106.59 - $164.21 $155,727 - $239,910
-1,461 Reduced 3.74%
37,621 $6.04 Million
Q3 2019

Nov 07, 2019

BUY
$113.31 - $150.51 $2.65 Million - $3.52 Million
23,398 Added 149.18%
39,082 $4.45 Million
Q2 2019

Aug 14, 2019

BUY
$115.0 - $141.58 $1.8 Million - $2.22 Million
15,684 New
15,684 $2.22 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $30B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.